Skip to main content
Clinical Trials/NCT01941472
NCT01941472CompletedNot Applicable

Transcutaneous pO2, Transcutaneous pCO2 and Central Venous SO2 Variations to Define Fluid Responsiveness

Peking Union Medical College Hospital1 site in 1 country40 target enrollmentStarted: September 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
1
Primary Endpoint
Fluid Responsiveness

Study Overview

Brief Summary

Fluid challenge is often carried out in critical ill patients. Its responsiveness usually requires invasive monitoring. To use non-invasive methods is very tempting. Investigators hypothesize that transcutaneous pO2,transcutaneous pCO2 and Central Venous SO2 variations provide feasible estimation on fluid responsiveness in critical ill patients.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Screening
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years and older ICU patients;
  • Septic shock;
  • Monitored with PICCO or Swan-Ganz catheter;
  • The decision of fluid challenge made by the treating physician;

Exclusion Criteria

  • Evidence of fluid overload;
  • Pregnancy

Outcomes

Primary Outcomes

Fluid Responsiveness

Time Frame: Immediately after fluid challenge, average 5 minutes

Increase in cardiac index ≥ 10% after fluid challenge

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Bin Du

Director of Medical ICU

Peking Union Medical College Hospital

Study Sites (1)

Loading locations...

Similar Trials